Niki BioSolutions, Inc. (NIKI) Shares Outstanding (2017 - 2025)

Niki BioSolutions (NIKI) has 9 years of Shares Outstanding (Entity) data on file, last reported at $444.1 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) fell 99.0% year-over-year to $444.1 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $444.1 million (down 99.0% YoY) and the FY2025 annual result came in at $73.5 billion, up 34.82% from the prior year.
• Shares Outstanding (Entity) retreated to $444.1 million in Q4 2025, from $44.4 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $45.2 billion in Q4 2023 to a low of $35695.0 in Q4 2022.
• A 5-year average of $18.2 billion and a median of $444.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) surged 126659936.42% — and 2025, when it plunged 99.0%.
• Tracing NIKI's Shares Outstanding (Entity) over 5 years: stood at $121561.0 in 2021, then plunged by 70.64% to $35695.0 in 2022, then surged by 126659936.42% to $45.2 billion in 2023, then declined by 1.77% to $44.4 billion in 2024, then sank by 99.0% to $444.1 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $444.1 million (Q4 2025), $44.4 billion (Q3 2025), and $444.1 million (Q2 2025), per Business Quant data.